@article{c74d508c82dc414c9e3273f5dfbe90eb,
title = "Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study",
abstract = "Recombinant human TSH (rhTSH) can be used to enhance (131)I therapy for shrinkage of multinodular goiter (MG). OBJECTIVE, DESIGN, AND SETTING: The objective of the study was to compare the efficacy and safety of 0.01 and 0.03 mg modified-release (MR) rhTSH as an adjuvant to (131)I therapy, vs. (131)I alone, in a randomized, placebo-controlled, international, multicenter study.",
keywords = "Adult, Aged, Aged, 80 and over, Anatomy, Cross-Sectional, Combined Modality Therapy, Delayed-Action Preparations, Double-Blind Method, Female, Goiter, Nodular, Humans, Iodine Radioisotopes, Male, Middle Aged, Quality of Life, Recombinant Proteins, Thyroid Function Tests, Thyroid Hormones, Thyroidectomy, Thyrotropin, Trachea",
author = "H Graf and S Fast and F Pacini and A Pinchera and A Leung and M Vaisman and C Reiners and Wemeau, {J L} and D Huysmans and Harper, {Willie F.} and A Driedger and {de Souza}, {H Noemberg} and Castagna, {M G} and L Antonangeli and L Braverman and R Corbo and C D{\"u}ren and E Proust-Lemoine and Edelbroek, {M A} and C Marriott and I Rachinsky and Peter Grupe and T Watt and J Magner and L Hegedus",
year = "2011",
doi = "10.1210/jc.2010-1193",
language = "English",
volume = "96",
pages = "1368--76",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The/Endocrine Society",
number = "5",
}